This study describes the molecular mechanisms by which CYP46A1 modulates neuronal outgrowth and function, highlighting the cholesterol 24-hydroxylase as an attractive drug target in the physiological and pathological context of cognitive decline and brain disorders. The gene discussed is CYP46A1; the disease is Mental deterioration.